Investigating Next-Generation Targets (BCMA, Solid Tumors) and Non-Viral Vector Systems: Key Focus Areas for India CAR T Cell Therapy Market research
  The current landscape of India CAR T Cell Therapy Market research is strategically focused on moving beyond the foundational CD19-targeting autologous therapies into next-generation innovations that address critical limitations. A significant research vector involves the development of CAR T-cells targeting new antigens, primarily B-Cell Maturation Antigen (BCMA) for the treatment of...
0 Comments 0 Shares 10 Views 0 Reviews